I'll give you a short answer. Right at the moment our price regulations apply at introduction. We are currently asking for discussions and proposals regarding a real-world efficacy after the drug has been on the market for a few years. But at the moment, we don't look at the price after introduction--
On February 7th, 2008. See this statement in context.